AU2003268020A1 - Treatment of depression secondary to pain (dsp) - Google Patents
Treatment of depression secondary to pain (dsp) Download PDFInfo
- Publication number
- AU2003268020A1 AU2003268020A1 AU2003268020A AU2003268020A AU2003268020A1 AU 2003268020 A1 AU2003268020 A1 AU 2003268020A1 AU 2003268020 A AU2003268020 A AU 2003268020A AU 2003268020 A AU2003268020 A AU 2003268020A AU 2003268020 A1 AU2003268020 A1 AU 2003268020A1
- Authority
- AU
- Australia
- Prior art keywords
- pain
- depression
- milnacipran
- dsp
- serotonin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39867602P | 2002-07-24 | 2002-07-24 | |
US60/398,676 | 2002-07-24 | ||
US44303503P | 2003-01-28 | 2003-01-28 | |
US60/443,035 | 2003-01-28 | ||
PCT/US2003/023088 WO2004009069A1 (fr) | 2002-07-24 | 2003-07-24 | Traitement de la depression consecutive a la douleur |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003268020A1 true AU2003268020A1 (en) | 2004-02-09 |
Family
ID=30773102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003268020A Abandoned AU2003268020A1 (en) | 2002-07-24 | 2003-07-24 | Treatment of depression secondary to pain (dsp) |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1545489A4 (fr) |
CN (1) | CN1671368A (fr) |
AU (1) | AU2003268020A1 (fr) |
CA (1) | CA2493490A1 (fr) |
MX (1) | MXPA05000566A (fr) |
WO (1) | WO2004009069A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200639162A (en) | 2005-03-14 | 2006-11-16 | Teva Pharma | Pure duloxetine hydrochloride |
FR2978350B1 (fr) | 2011-07-28 | 2013-11-08 | Pf Medicament | Medicament a base de levomilnacipran pour la rehabilitation fonctionnelle apres accident neurologique aigu |
CN112500361B (zh) * | 2020-12-27 | 2023-05-12 | 甘肃瀚聚药业有限公司 | 一种(s)-4-苯基-2-恶唑烷酮的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0647134A4 (fr) * | 1992-06-23 | 1997-07-30 | Sepracor Inc | Procedes et compositions utilises pour traiter la depression et d'autres affections avec de la sibutramine (-) optiquement pure. |
CA2134038C (fr) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentialisation des effets de medicaments |
US6635675B2 (en) * | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
-
2003
- 2003-07-24 CA CA002493490A patent/CA2493490A1/fr not_active Abandoned
- 2003-07-24 CN CNA038174588A patent/CN1671368A/zh active Pending
- 2003-07-24 WO PCT/US2003/023088 patent/WO2004009069A1/fr not_active Application Discontinuation
- 2003-07-24 AU AU2003268020A patent/AU2003268020A1/en not_active Abandoned
- 2003-07-24 EP EP03748971A patent/EP1545489A4/fr not_active Withdrawn
- 2003-07-24 MX MXPA05000566A patent/MXPA05000566A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1671368A (zh) | 2005-09-21 |
WO2004009069A1 (fr) | 2004-01-29 |
EP1545489A1 (fr) | 2005-06-29 |
MXPA05000566A (es) | 2005-08-29 |
EP1545489A4 (fr) | 2006-08-23 |
CA2493490A1 (fr) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040034101A1 (en) | Treatment and prevention of depression secondary to pain (DSP) | |
US7888342B2 (en) | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain | |
AU2003284005B2 (en) | Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders | |
EP2322225B1 (fr) | Inhibiteurs sélectifs de récaptage de la norépinéphrine et de la sérotonine utilisés dans le traitement du syndrome de la fibromyosite, de l'encéphalo-myélite myalgique et de la douleur | |
US20080096872A1 (en) | Composition for Treatment of Pain Specification | |
US20130236573A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
CN102573823B (zh) | 包含反式去甲舍曲林和血清素受体1a激动剂/拮抗剂的组合物及其用途 | |
AU2016203771A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
Lew | Selegiline orally disintegrating tablets for the treatment of Parkinson’s disease | |
ES2390225T3 (es) | Combinación del analéptico modafinilo y de un antidepresivo para el tratamiento de la depresión | |
AU2003268020A1 (en) | Treatment of depression secondary to pain (dsp) | |
CA2973540A1 (fr) | Traitement de maladie auto-immune chez un patient recevant en outre un betabloquant | |
Korn et al. | Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline | |
EP1261324B1 (fr) | Utilisation du tramadol pour la preparation d'un medicament pour le traitement de troubles gastro-intestinaux fonctionnels | |
AU2013203567A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
AU2012307535A1 (en) | Combinations comprising a S1P receptor modulator | |
AU2013201492A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |